Advanced Search

Study Preview



Study Title and Description

Benign gynecologic conditions among participants in the Breast Cancer Prevention Trial.



Key Questions Addressed
3 Key Question 3. What are the harms of using medications to reduce risk for primary breast cancer? Key Question 3a. Do harms of risk-reducing medications vary by timing of initiation and/or duration of use? Key Question 3b. Do harms of risk-reducing medications persist beyond discontinuation of use?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Benign gynecologic conditions among participants in the Breast Cancer Prevention Trial.
Author Chalas E., Costantino JP., Wickerham DL., Wolmark N., Lewis GC., Bergman C., Runowicz CD.
Country Department of Obstetrics, Gynecology and Reproductive Medicine, Stony Brook University, State University of New York, Stony Brook, NY, USA.echalas78@hotmail.com
Year 2005
Numbers Pubmed ID: 15846210

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Key Questions 1-4


Results & Comparisons

No Results found.